Tuberculosis 2012: Biology, Pathogenesis, Intervention Strategies
Institut Pasteur, Paris, France
Registration is now open via the conference wesite.
TBVI is sponsor of this symposium and our director Jelle Thole will chair the session 'Novel vaccine stragegies'. Several TBVI partners will be present as speaker.
Tuberculosis remains an enormous burden to human health, even at the beginning of the 21st century. The situation is worsening in many countries, particularly due to the synergy with the HIV epidemic and the appearance of multi-drug resistant (MDR) or extensively-drug resistant (XDR) tuberculosis. The urgently needed development of new tools that can improve the diagnosis, prevention and/or therapy of tuberculosis and other major mycobacterial diseases depends largely on the progress made by basic and applied research.
The international conference "Tuberculosis 2012" provides a premium forum for the discussion and exchange of the recent advances of current research and novel trends related to tuberculosis, its causative agent Mycobacterium tuberculosis and related pathogenic mycobacteria. This international meeting to be held from September 11-15, 2012, will take place in the Conference centre (CIS) within the campus of the Institut Pasteur, which can host up to 500 conference delegates and is situated in the center of Paris, France.
The conference will be of interest to researchers, doctors, and representatives from industry with focus on the biology of pathogenic mycobacteria and their interaction with their hosts. Participation by students and scientists in the early stages of their careers is highly encouraged. Tuberculosis 2012 will provide abundant opportunities for networking and exchange of information between senior scientists and professionals, new investigators and students.
Important Dates:
Online registration opens:
December, 2011
Early fee registration deadline:
June 15, 2012
Abstract submission deadline:
June 15, 2012
For more information, look at the conference website here
Contact
Ms. Erna Balk
Director Communications & Advocacy Relations
+31 320 277 552
erna.balk(at)tbvi.eu